Peripheral arterioportal fistula: Demonstration with contrast-enhanced sonography

Orlando Catalano, Alfredo Siani

Research output: Contribution to journalArticlepeer-review

Abstract

Contrast-enhanced sonography (CES) is used with increasing frequency in the assessment of liver focal lesions that have undergone percutaneous ablation therapies. 5 We report a case in which the CES study performed after percutaneous ethanol injection therapy for hepatocellular carcinoma (HCC) showed a perifocal arterioportal fistula. The clues to diagnosis included transient hyperechogenicity of perinodular parenchyma during the arterial phase of enhancement and early opacification of peripheral portal branches adjacent to the treated nodule. Fistula formation was probably due to recent ethanol injections. To our knowledge, there are no previous reports describing the CES features of a peripheral arterioportal fistula.

Original languageEnglish
Pages (from-to)1027-1030
Number of pages4
JournalJournal of Ultrasound in Medicine
Volume24
Issue number7
Publication statusPublished - Jul 2005

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Acoustics and Ultrasonics

Fingerprint

Dive into the research topics of 'Peripheral arterioportal fistula: Demonstration with contrast-enhanced sonography'. Together they form a unique fingerprint.

Cite this